Interestingly, a secondary tauopathy characterised by brain deposition of abnormal p-tau aggregates has been demonstrated in all these atypical phenotypes of prion disease by post-mortem studies [26, 27, 31, 58], although the data on VPSPr are very limited. This evidence concerns the gene MAPT and tauopathy.